SCHEMBL4156189

SCHEMBL4156189

CC(=O)c1cccc(NC(=O)[C@H](CCCSCC(=O)C(F)(F)F)NC(=O)Cn2c(=O)oc3ccccc32)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C19 P33261 1/20 0.48
POLB P06746 8/20 0.47
CBX7 O95931 2/20 0.46
CDYL2 Q8N8U2 2/20 0.46
CDYL Q9Y232 2/20 0.46
CDY1; CDY1B Q9Y6F8 2/20 0.46
RECQL P46063 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
KMT2A Q03164 5/20 0.46
MEN1 O00255 4/20 0.46
MAPT P10636 2/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
APEX1 P27695 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4621007 0.88 POLB (0.51) CYP1A2CYP3A4CYP2D6CYP2C19POLB
SCHEMBL4174395 0.81 ALDH1A1 (0.48) CYP1A2CYP3A4CYP2D6CYP2C19POLB
SCHEMBL4620748 0.81 LMNA (0.40) CYP1A2CYP3A4CYP2D6CYP2C19POLB
SCHEMBL5125260 0.80 CYP1A2 (0.52) CYP1A2CYP3A4CYP2D6CYP2C19POLB
SCHEMBL4160412 0.79 HTT (0.46) CYP1A2CYP3A4CYP2D6CYP2C19POLB
SCHEMBL3507991 0.79 ALDH1A1 (0.45) CYP1A2CYP3A4CYP2D6CYP2C19POLB
SCHEMBL4164026 0.79 ALDH1A1 (0.54) CYP1A2CYP3A4CYP2D6CYP2C19POLB
SCHEMBL4156192 0.78 CYP1A2 (0.44) CYP1A2CYP3A4CYP2C19CBX7CDYL2
Trifluoroacetic Acid SCHEMBL4622701 0.76 CHRM1 (0.46)
SCHEMBL4166185 0.76 NPC1 (0.42) CYP1A2CYP3A4CYP2D6CYP2C19POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors JONES PHILIP 2009-02-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090054448-A1 Amino Acid Derivatives as Histone Deacetylase (HDAC) Inhibitors HDAC5, HDAC1, HDAC11 CYP1A2 2863/4885CYP3A4 3542/4885CYP2D6 3094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.